00950.HK
Lee's Pharmaceutical Holdings Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK
HKD 1.03
−2.37%Year over year
Reported trailing growth
- Revenue
- +34.8%
- EBITDA
- +7.4%
- EBIT
- —
- EPS
- +70.3%
- Free cash flow
- +27.2%
- Operating cash flow
- +57.2%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +5.2%
- EBITDA
- +5.1%
- EBIT
- +3.9%
- Net income
- +21.5%
- EPS
- +22.5%
- Free cash flow
- +13.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026